Biopharma companies require optimal clone yields to ensure maximum concentration and effectiveness of these therapeutic ...

When the researchers knocked out this gene circuit, the CHO cells stopped producing lactic acid. Moreover, the cells demonstrated improved growth and, compared to similarly treated controls ...

Lotte Biologics announced on the 13th that it has signed a memorandum of understanding (MOU) for collaboration in the ...

Proprietary Methodology Shows Potential to Improve Yield, Quality and Function of Cell Derived Therapies BOSTON, MA, UNITED STATES, March 4, 2 ...

U.S. cellular starting materials Market Size was valued at USD 0.68 Billion in 2024 and is expected to reach USD 4.45 Billion by 2034 growing at a CAGR of 20.4%.